Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Characteristics of Cryopyrin-Associated Periodic Syndrome and Long-Term Real-World Efficacy and Tolerability of Canakinumab in Japan: Results of a Nationwide Survey.
Miyamoto T, Izawa K, Masui S, Yamazaki A, Yamasaki Y, Matsubayashi T, Shiraki M, Ohnishi H, Yasumura J, Kawabe T, Miyamae T, Matsubara T, Arakawa N, Ishige T, Takizawa T, Shimbo A, Shimizu M, Kimura N, Maeda Y, Maruyama Y, Shigemura T, Furuta J, Sato S, Tanaka H, Izumikawa M, Yamamura M, Hasegawa T, Kaneko H, Nakagishi Y, Nakano N, Iida Y, Nakamura T, Wakiguchi H, Hoshina T, Kawai T, Murakami K, Akizuki S, Morinobu A, Ohmura K, Eguchi K, Sonoda M, Ishimura M, Furuno K, Kashiwado M, Mori M, Kawahata K, Hayama K, Shimoyama K, Sasaki N, Ito T, Umebayashi H, Omori T, Nakamichi S, Dohmoto T, Hasegawa Y, Kawashima H, Watanabe S, Taguchi Y, Nakaseko H, Iwata N, Kohno H, Ando T, Ito Y, Kataoka Y, Saeki T, Kaneko U, Murase A, Hattori S, Nozawa T, Nishimura K, Nakano R, Watanabe M, Yashiro M, Nakamura T, Komai T, Kato K, Honda Y, Hiejima E, Yonezawa A, Bessho K, Okada S, Ohara O, Takita J, Yasumi T, Nishikomori R; Japan CAPS Working Group. Miyamoto T, et al. Among authors: nishimura k. Arthritis Rheumatol. 2024 Jan 25. doi: 10.1002/art.42808. Online ahead of print. Arthritis Rheumatol. 2024. PMID: 38268504
Validation of Classification Criteria of Macrophage Activation Syndrome in Japanese Patients With Systemic Juvenile Idiopathic Arthritis.
Shimizu M, Mizuta M, Yasumi T, Iwata N, Okura Y, Kinjo N, Umebayashi H, Kubota T, Nakagishi Y, Nishimura K, Yashiro M, Yasumura J, Yamazaki K, Wakiguchi H, Okamoto N, Mori M. Shimizu M, et al. Among authors: nishimura k. Arthritis Care Res (Hoboken). 2018 Sep;70(9):1412-1415. doi: 10.1002/acr.23482. Epub 2018 Jul 5. Arthritis Care Res (Hoboken). 2018. PMID: 29195002
Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ).
Yasumura J, Yashiro M, Okamoto N, Shabana K, Umebayashi H, Iwata N, Okura Y, Kubota T, Shimizu M, Tomiita M, Nakagishi Y, Nishimura K, Hara R, Mizuta M, Yasumi T, Yamaide F, Wakiguchi H, Kobayashi M, Mori M. Yasumura J, et al. Among authors: nishimura k. Pediatr Rheumatol Online J. 2019 Apr 11;17(1):15. doi: 10.1186/s12969-019-0318-5. Pediatr Rheumatol Online J. 2019. PMID: 30975163 Free PMC article.
Clinical impact of myositis-specific autoantibodies on long-term prognosis of juvenile idiopathic inflammatory myopathies: multicentre study.
Yamasaki Y, Kobayashi N, Akioka S, Yamazaki K, Takezaki S, Nakaseko H, Ohara A, Nishimura K, Nishida Y, Sato S, Kishi T, Hashimoto M, Mori M, Okazaki Y, Kuwana M, Ohta A. Yamasaki Y, et al. Among authors: nishimura k. Rheumatology (Oxford). 2021 Oct 2;60(10):4821-4831. doi: 10.1093/rheumatology/keab108. Rheumatology (Oxford). 2021. PMID: 33576399
Treatment for macrophage activation syndrome associated with systemic juvenile idiopathic arthritis in Japan.
Shimizu M, Nishimura K, Iwata N, Yasumi T, Umebayashi H, Nakagishi Y, Okura Y, Okamoto N, Kinjo N, Mizuta M, Yashiro M, Yasumura J, Wakiguchi H, Kubota T, Mouri M, Kaneko U, Mori M. Shimizu M, et al. Among authors: nishimura k. Int J Rheum Dis. 2023 May;26(5):938-945. doi: 10.1111/1756-185X.14681. Epub 2023 Mar 27. Int J Rheum Dis. 2023. PMID: 36973039
Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
Shimizu M, Mizuta M, Okamoto N, Yasumi T, Iwata N, Umebayashi H, Okura Y, Kinjo N, Kubota T, Nakagishi Y, Nishimura K, Mohri M, Yashiro M, Yasumura J, Wakiguchi H, Mori M. Shimizu M, et al. Among authors: nishimura k. Pediatr Rheumatol Online J. 2020 Jan 10;18(1):2. doi: 10.1186/s12969-020-0399-1. Pediatr Rheumatol Online J. 2020. PMID: 31924225 Free PMC article.
4,119 results